(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) slid by a staggering 23.91% in 14 days from $0.46 to $0.35 at 17:10 EST on Monday, after two successive sessions in a row of gains. NASDAQ is jumping 0.59% to $14,893.75, following the last session’s upward trend.
TherapeuticsMD’s last close was $0.35, 87.45% under its 52-week high of $2.75.
Today’s last reported volume for TherapeuticsMD is 3244219 which is 46.09% below its average volume of 6018655.
TherapeuticsMD’s sales growth is 33.7% for the present quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.38%, a negative 0.77%, and a positive 5.81%, respectively.
TherapeuticsMD’s highest amplitude of average volatility was 3.40% (last week), 4.35% (last month), and 5.81% (last quarter), respectively.
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.35 at 17:10 EST, below its 52-week low of $0.37.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way below its 50-day moving average of $0.66 and way under its 200-day moving average of $1.00.
More news about TherapeuticsMD (TXMD).